PYZTERLA

Class [005]
Human pharmaceuticals for treatment of cancer; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; pharmaceutical antibody preparations for auto-immune diseases; botanicals for the treatment of inflammatory bowel disease and connective tissue diseases; botanicals for the treatment of cancer; cardiovascular treatment preparations; gastrointestinal treatment preparations; haemorrhoid treatment preparations; neurological pharmaceutical preparations for the prevention and treatment of Alzheimer's, Huntington's disease, and cerebral palsy; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations for diagnosing and treating neurodegenerative diseases; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products in the treatment of oncological diseases; medicinal preparations for use in oncology; medicines for the treatment of mental health disorders; natural medicines for improving brain function; natural medicines for improving heart function; natural medicines for improving immune system function; natural medicines for improving liver function; natural medicines for improving lung function; pharmaceutical preparations for use in hematology; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for the treatment of ulcerative colitis; antidiabetic preparations; human vaccine preparations; biological preparations made from human blood cells for the treatment of cancer; biological preparations made from living tissues for the treatment of cancer; biological preparations made from living tissues for use in immunotherapy; biological preparations made from living tissues for use in cell therapy; biological preparations made from living tissues for use in gene therapy; biochemical preparations containing psilocybin mushrooms in powdered form for the treatment of mental health disorders; anti-inflammatory preparations; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; human pharmaceutical preparations for the prevention and treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for human use in the field of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; medicated topical skin preparations for the treatment of eczema; medicated topical skin preparations for the treatment of rosacea; medicated topical skin preparations for the treatment of severe dry and itchy skin; natural medicines for improving skin health; pharmaceutical preparations for the treatment of skin cancer; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and treatment of acne; pharmaceutical preparations for psoriasis treatment; pharmaceutical preparations for the treatment of psoriatic arthritis; pharmaceutical preparations for the treatment of Crohn's disease.